chr4-112646348-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016648.4(LARP7):c.203-3T>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,348,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016648.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LARP7 | NM_016648.4 | c.203-3T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000344442.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LARP7 | ENST00000344442.10 | c.203-3T>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 2 | NM_016648.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000289 AC: 66AN: 228530Hom.: 0 AF XY: 0.000225 AC XY: 28AN XY: 124360
GnomAD4 exome AF: 0.000105 AC: 125AN: 1196136Hom.: 0 Cov.: 16 AF XY: 0.000102 AC XY: 62AN XY: 607446
GnomAD4 genome AF: 0.000118 AC: 18AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74478
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2021 | This sequence change falls in intron 2 of the LARP7 gene. It does not directly change the encoded amino acid sequence of the LARP7 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201651306, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with LARP7-related conditions. ClinVar contains an entry for this variant (Variation ID: 452711). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 10, 2017 | The c.203-3 T>G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.203-3 T>G variant is observed in 50/29132 (0.2%) alleles from individuals of Latino background (Lek et al., 2016). This variant is predicted to damage or destroy the splice acceptor site in intron 2, and is expected to cause abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Additionally, this substitution occurs at a position that is not conserved. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
LARP7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 08, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at